Aphria (NASDAQ:APHA) Stock Price Down 5.1%


Share on StockTwits

Aphria Inc. (NASDAQ:APHA) dropped 5.1% on Tuesday . The stock traded as low as $17.22 and last traded at $17.27. Approximately 465,229 shares changed hands during trading, a decline of 98% from the average daily volume of 24,610,459 shares. The stock had previously closed at $18.19.

APHA has been the topic of several research reports. Cantor Fitzgerald upped their price objective on shares of Aphria from $26.00 to $32.50 and gave the company an “overweight” rating in a report on Tuesday, February 16th. BMO Capital Markets upped their price objective on shares of Aphria from $7.00 to $15.00 and gave the company a “market perform” rating in a report on Friday, January 15th. Alliance Global Partners upped their price objective on shares of Aphria from $12.00 to $20.00 and gave the company a “buy” rating in a report on Friday, January 15th. Zacks Investment Research upgraded shares of Aphria from a “strong sell” rating to a “hold” rating in a report on Monday, March 22nd. Finally, CIBC upped their price objective on shares of Aphria from $18.00 to $28.00 and gave the company an “outperform” rating in a report on Monday, February 22nd. Four research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $18.53.

The company has a quick ratio of 1.17, a current ratio of 2.36 and a debt-to-equity ratio of 0.25. The firm’s 50-day moving average price is $18.57 and its 200 day moving average price is $11.42. The company has a market capitalization of $5.13 billion, a P/E ratio of -27.44 and a beta of 2.67.

Aphria (NASDAQ:APHA) last issued its quarterly earnings data on Wednesday, January 13th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.03) by ($0.39). Aphria had a negative return on equity of 2.30% and a negative net margin of 36.10%. The firm had revenue of $160.50 million during the quarter, compared to the consensus estimate of $153.75 million. During the same period in the previous year, the company posted ($0.03) earnings per share. The company’s revenue for the quarter was up 33.1% on a year-over-year basis. As a group, equities research analysts expect that Aphria Inc. will post -0.06 EPS for the current year.

Several institutional investors have recently added to or reduced their stakes in APHA. Cahaba Wealth Management Inc. lifted its stake in shares of Aphria by 8.1% during the 4th quarter. Cahaba Wealth Management Inc. now owns 23,587 shares of the company’s stock valued at $304,000 after buying an additional 1,769 shares in the last quarter. Truist Financial Corp lifted its stake in Aphria by 16.2% in the 4th quarter. Truist Financial Corp now owns 13,024 shares of the company’s stock worth $90,000 after purchasing an additional 1,814 shares in the last quarter. Liberty Wealth Management LLC purchased a new stake in Aphria in the 4th quarter worth approximately $43,000. Johnson Midwest Financial LLC purchased a new stake in Aphria in the 4th quarter worth approximately $25,000. Finally, Valeo Financial Advisors LLC purchased a new stake in Aphria in the 4th quarter worth approximately $28,000. 10.30% of the stock is owned by hedge funds and other institutional investors.

About Aphria (NASDAQ:APHA)

Aphria Inc cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands.

Read More: Dividend Yield

Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.